Update: Valve have confirmed to RPS that this withdrawal of support for Steam transactions by one of PayPal's acquiring banks "is regarding content on Steam, related to what we’ve previously commented ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The day has ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Joe Supan is a senior writer for CNET covering home technology, broadband, and moving. Prior to joining CNET, Joe led MyMove's moving coverage and reported on broadband policy, the digital divide, and ...

Microsoft Defender is good now, but I still treat it like a simple lock instead of a full security system. Marshall Gunnell is a Tokyo-based tech journalist and editor with over a decade of experience ...

March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...

Amber Hussain-Siddique says operational discipline in inventory and logistics is the vital, yet overlooked, key to sustaining low-cost generic drug supplies in the U.S. Disclaimer: The views and ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

Persistent shortages (216 active at end‑2025) impose major operational costs (~$900M labor/year) and hit oncology, anesthesia, and emergency care, forcing substitutions and compounding with safety and ...